FDA Webview Site FDA Review Site FDA Updater Site
header.gif
Username:
Password:
 

human drugs
animal drugs
biologics
eirs 483s
medical devices
marketing
email
search our site
  
FDA-RELATED NEWS
 
 
 
TXT Ex-HHS Law Chief Astrue Blasts FDA on Fast-track Drugs [590 Words]
04/14/2014
 
 
TXT Social Media Guidance ‘Ambiguous, Overly Broad’: Comments [589 Words]
04/16/2014
 
 
TXT Drug Companies Improving Clinical Success Rates [381 Words]
04/16/2014
 
 
TXT Don’t Let REMS Interfere with Pharmacy Boards: RPh Group [506 Words]
04/15/2014
 
 
TXT Latest Federal Register Notices [1302 Words]
04/20/2014
 
 
TXT Since Our Last Issue ... [328 Words]
04/20/2014
 
 
TXT Product Approval Summaries [477 Words]
04/20/2014
 
 
TXT AstraZeneca, Pfizer Working on UK Cancer Drug Trial [291 Words]
04/17/2014
 
 
TXT FDA Touts Strategic Engagement with Chinese Regulators [342 Words]
04/17/2014
 
 
TXT Venture Capitalists Push Conditional Drug Approval [442 Words]
04/17/2014
 
 
TXT Arkansas Court Decision Supports FDA Regulatory Primacy: Article [514 Words]
04/17/2014
 
 
TXT FDA Denies Petition on Opioid Labeling [462 Words]
04/17/2014
 
 
TXT FDA Discouraging Laparoscopic Power Morcellation Uses [433 Words]
04/17/2014
 
 
TXT Bill Gives Doomed Patients Access To Unapproved Products [281 Words]
04/16/2014
 
 
TXT FDA Guidance on Endotoxin Limit for Intraocular Devices [126 Words]
04/16/2014
 
 
TXT FDA Issues Draft Case Presentation Guidance [357 Words]
04/16/2014
 
 
TXT FDA Warns American Medical Systems After Inspection [156 Words]
04/16/2014
 
 
TXT QS Problems Seen in LumiQuick Diagnostics Inspection [379 Words]
04/15/2014
 
 
TXT Government Intervenes in Orbit Medical False Claims Suit [189 Words]
04/15/2014
 
 
TXT FDA Approves Medac Pharma’s Rasuvo Trade Name [69 Words]
04/15/2014
 
 
TXT FDA Disallows Investigator-Sponsored IND for Retrophin Trial [190 Words]
04/15/2014
 
 
TXT Court Blocks Massachusetts Ban on Zohydro ER [220 Words]
04/15/2014
 
 
TXT Latest FDA Warning Letters [489 Words]
04/15/2014
 
 
TXT Mylan, Warner Chilcott Settle Generess Patent Dispute [262 Words]
04/15/2014
 
 
TXT CDRH Updates UDI Database Files [86 Words]
04/14/2014
 
 
TXT Workshop Next Month on Drug Supply Chain Security [159 Words]
04/14/2014
 
 
TXT Solomon Promoted to Deputy ACRA [142 Words]
04/14/2014
 
 
 
 
The most authoritative FDA news analysis each week is found in the pages of Dickinson's FDA Review. Since 1984, this newsletter has been providing in-depth reports on the most significant FDA developments affecting the pharmaceutical, medical device, biologics and veterinary medicines industries. Unlike other media, FDA Review eliminates time-wasting minutia and presents in clear, concise language the essence of what's really important - and why. It is the publication that FDA officials themselves read. Delivered in the middle of each week, FDA Review presents:
  • The latest agency policy developments, often before they're officially announced;
  • Major news insights, follow-ups and reactions in each product area;
  • Summaries of the latest Warning Letters;
  • The newest product approvals;
  • Summaries of the latest FDA Federal Register notices;
  • Summaries of DDMAC letters;
  • Related industry news capsules;
  • The industry's most concise FDA news index;
  • Inside-FDA news briefs
You can rely on FDA Review to provide only what's important - in the most convenient and time-saving